These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 3058971)
1. The diagnostic significance of the antiperinuclear factor for rheumatoid arthritis. Janssens X; Veys EM; Verbruggen G; Declercq L J Rheumatol; 1988 Sep; 15(9):1346-50. PubMed ID: 3058971 [TBL] [Abstract][Full Text] [Related]
2. Antiperinuclear factor: indicator of more severe disease in seronegative rheumatoid arthritis. Westgeest AA; Boerbooms AM; Jongmans M; Vandenbroucke JP; Vierwinden G; van de Putte LB J Rheumatol; 1987 Oct; 14(5):893-7. PubMed ID: 3501470 [TBL] [Abstract][Full Text] [Related]
3. Clinical heterogeneity of rheumatoid arthritis and the antiperinuclear factor. Manera C; Franceschini F; Cretti L; Braga S; Cattanec R J Rheumatol; 1994 Nov; 21(11):2021-5. PubMed ID: 7869304 [TBL] [Abstract][Full Text] [Related]
4. Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process. Aho K; von Essen R; Kurki P; Palosuo T; Heliövaara M J Rheumatol; 1993 Aug; 20(8):1278-81. PubMed ID: 7693940 [TBL] [Abstract][Full Text] [Related]
5. Antiperinuclear factor as a prognostic marker in rheumatoid arthritis. Muñoz-Fernández S; Alvarez-Doforno R; González-Tarrio JM; Balsa A; Richi P; Fontán G; Gijón-Baños J; Martin-Mola E J Rheumatol; 1999 Dec; 26(12):2572-7. PubMed ID: 10606364 [TBL] [Abstract][Full Text] [Related]
6. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694 [TBL] [Abstract][Full Text] [Related]
8. [Comparative characteristics of specific autoantibodies in rheumatoid arthritis]. Lapin SV; Maslianskiĭ AL; Mazurov VI; Totolian AA Ter Arkh; 2005; 77(12):53-9. PubMed ID: 16514821 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis. Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440 [TBL] [Abstract][Full Text] [Related]
10. [Antiperinuclear factors in psoriasis. Correlation with other serological abnormalities in 90 patients]. Youinou P; Massé R; Peu-Duvallon P; Le Roux P; Grulier A; Miossec P; Dorval JC; Lizan G; Férec C; Le Goff P Ann Dermatol Venereol; 1982; 109(4):359-64. PubMed ID: 6751193 [TBL] [Abstract][Full Text] [Related]
11. Anti-CCP2 is an adjunct to, not a surrogate for, rheumatoid factor in the diagnosis of rheumatoid arthritis: diagnostic utility of anti-CCP2 antibodies in Egyptian patients with rheumatoid arthritis. Abdel-Nasser AM; Mahmoud MH; El Mansoury TM; Osman AM Scand J Rheumatol; 2008; 37(5):329-36. PubMed ID: 18666028 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of anti-RA33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early rheumatoid arthritis: comparison with rheumatoid factor. Cordonnier C; Meyer O; Palazzo E; de Bandt M; Elias A; Nicaise P; Haïm T; Kahn MF; Chatellier G Br J Rheumatol; 1996 Jul; 35(7):620-4. PubMed ID: 8670593 [TBL] [Abstract][Full Text] [Related]
13. Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. Hayem G; Chazerain P; Combe B; Elias A; Haim T; Nicaise P; Benali K; Eliaou JF; Kahn MF; Sany J; Meyer O J Rheumatol; 1999 Jan; 26(1):7-13. PubMed ID: 9918234 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of antikeratin antibodies in rheumatoid arthritis. Ordeig J; Guardia J J Rheumatol; 1984 Oct; 11(5):602-4. PubMed ID: 6210364 [TBL] [Abstract][Full Text] [Related]
15. Specificity of antiperinuclear factor for rheumatoid arthritis in rheumatoid factor-positive sera. Berthelot JM; Maugars Y; Audrain M; Youinou P; Prost A Br J Rheumatol; 1995 Aug; 34(8):716-20. PubMed ID: 7551653 [TBL] [Abstract][Full Text] [Related]
16. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. Liu X; Jia R; Zhao J; Li Z J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic value for rheumatoid arthritis of antiperinuclear factor at the 1:100 threshold. Study of 600 patients and meta-analysis of the literature. Berthelot JM; Garnier P; Glémarec J; Flipo RM Rev Rhum Engl Ed; 1998 Jan; 65(1):9-14. PubMed ID: 9523380 [TBL] [Abstract][Full Text] [Related]
18. Adult seronegative arthritis with antinuclear antibodies: a distinct group of patients with a different immunogenetic pattern from seropositive rheumatoid arthritis and a good outcome. Saudan-Kister A; Gabay C; Tiercy JM; Mermillod B; Guerne PA; Vischer TL Rev Rhum Engl Ed; 1996 May; 63(5):313-20. PubMed ID: 8789876 [TBL] [Abstract][Full Text] [Related]
19. [Antiperinuclear antibodies and corrisponding antigens]. Youinou P; Berthelot JM; Péron A; Leroux AM; Le Goff P Rev Rhum Mal Osteoartic; 1992 Sep; 59(6 Pt 2):43S-51S. PubMed ID: 1485130 [TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic rheumatism. Gonzalez-Lopez L; Gamez-Nava JI; Jhangri GS; Ramos-Remus C; Russell AS; Suarez-Almazor ME J Rheumatol; 1999 Mar; 26(3):540-5. PubMed ID: 10090159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]